These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18696022)

  • 21. Is routine ultrasound guidance really necessary for closure of patent foramen ovale using the Amplatzer PFO occluder?
    Fateh-Moghadam S; Steeg M; Dietz R; Bocksch W
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):361-6. PubMed ID: 19133676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patent foramen ovale closure with the SeptRx device initial experience with the first "In-Tunnel" device.
    Zimmermann WJ; Heinisch C; Majunke N; Staubach S; Russell S; Wunderlich N; Sievert H
    JACC Cardiovasc Interv; 2010 Sep; 3(9):963-7. PubMed ID: 20850097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early-mid term follow-up results of percutaneous closure of the interatrial septal defects with occlutech figulla devices: a single center experience.
    Aytemir K; Oto A; Ozkutlu S; Kaya EB; Canpolat U; Yorgun H; Sahiner L; Kabakçi G
    J Interv Cardiol; 2012 Aug; 25(4):375-81. PubMed ID: 22612236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk and fate of residual interatrial shunting after transcatheter closure of patent foramen ovale: a long term follow up study.
    Hammerstingl C; Bauriedel B; Stüsser C; Momcilovic D; Tuleta I; Nickenig G; Skowasch D
    Eur J Med Res; 2011 Jan; 16(1):13-9. PubMed ID: 21345765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New PFO device for closure of patent foramen ovale in patients who had a history of cryptogenic stroke; a report of 14 cases.
    Srimahachota S; Sansanayudh N; Lertsuwunseri V; Cholteesupachai J; Lertsapcharoen P
    J Med Assoc Thai; 2015 Jan; 98 Suppl 1():S107-10. PubMed ID: 25764621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous closure of inter-atrial communications (atrial septal defect and patent foramen ovale): single-centre experience and mid-term follow-up.
    Van de Bruaene A; Stroobants D; Benit E
    Acta Cardiol; 2015 Apr; 70(2):133-40. PubMed ID: 26148372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The new patent foramen ovale occluder FIGULLA in complex septal anatomy: a case series.
    Baglini R; Baldari D; Amaducci A; D'Ancona G
    Ther Adv Cardiovasc Dis; 2013 Feb; 7(1):21-6. PubMed ID: 23238514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of residual shunt rates in five devices used to treat patent foramen ovale.
    Matsumura K; Gevorgyan R; Mangels D; Masoomi R; Mojadidi MK; Tobis J
    Catheter Cardiovasc Interv; 2014 Sep; 84(3):455-63. PubMed ID: 24550064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous atrial shunt closure using the novel Occlutech Figulla device: 6-month efficacy and safety.
    Van Den Branden BJ; Post MC; Plokker HW; Ten Berg JM; Suttorp MJ
    J Interv Cardiol; 2011 Jun; 24(3):264-70. PubMed ID: 21198853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the amplatzer PFO occluder without intraprocedural echocardiography: effect of device size.
    Wahl A; Tai T; Praz F; Schwerzmann M; Seiler C; Nedeltchev K; Windecker S; Mattle HP; Meier B
    JACC Cardiovasc Interv; 2009 Feb; 2(2):116-23. PubMed ID: 19463412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
    Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single centre experience with GORE-HELEX septal occluder for closure of PFO.
    Ponnuthurai FA; van Gaal WJ; Burchell A; Mitchell A; Wilson N; Ormerod O
    Heart Lung Circ; 2009 Apr; 18(2):140-2. PubMed ID: 18294910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous closure of the patent foramen ovale using the HELEX® Septal Occluder: acute and long-term results in 405 patients.
    Heinisch C; Bertog S; Wunderlich N; Majunke N; Baranowski A; Leetz M; Fischer E; Staubach S; Zimmermann W; Hofmann I; Sievert H
    EuroIntervention; 2012 Oct; 8(6):717-23. PubMed ID: 23086790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous transcatheter closure of patent foramen ovale with the Amplatzer Cribriform septal occluder.
    Silvestry FE; Naseer N; Wiegers SE; Hirshfeld JW; Herrmann HC
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):383-7. PubMed ID: 18288733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Percutaneous closure of interatrial septal defects: mid-term follow-up results].
    Oto MA; Aytemir K; Ozkutlu S; Kaya EB; Kabakcı G; Ateş AH; Yorgun H; Canpolat U
    Turk Kardiyol Dern Ars; 2011 Jul; 39(5):385-95. PubMed ID: 21743262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices.
    Bissessor N; Wong AW; Hourigan LA; Jayasinghe RS; Scalia GS; Burstow DJ; Griffiths LR; Savage M; Walters DL
    Cardiovasc Revasc Med; 2011; 12(3):164-169. PubMed ID: 21640934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of percutaneous closure of patent foramen ovale with the GORE(®) septal occluder.
    Knerr M; Bertog S; Vaskelyte L; Hofmann I; Sievert H
    Catheter Cardiovasc Interv; 2014 Jun; 83(7):1144-51. PubMed ID: 24323667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcatheter PFO closure with GORE(®) septal occluder: early and mid-term clinical results.
    Butera G; Saracino A; Danna P; Sganzerla P; Chessa M; Carminati M
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):944-9. PubMed ID: 23897659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcranial Doppler quantification of residual shunt after percutaneous patent foramen ovale closure. Comparison of two devices.
    Sorensen SG; Aguilar H; McKnight WK; Thomas H; Muhlestein JB
    J Interv Cardiol; 2010 Dec; 23(6):575-80. PubMed ID: 20796165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors and clinical outcomes of residual shunt in patients undergoing percutaneous transcatheter closure of patent foramen ovale.
    Zajarias A; Thanigaraj S; Lasala J; Perez J
    J Invasive Cardiol; 2006 Nov; 18(11):533-7. PubMed ID: 17090816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.